Testing might allow for a substantial reduction in the length of, or replacement of,quarantine with a small excess in transmission risk. Decreasing test and trace...
Even rigorous RT-PCR testing protocols might miss a substantial proportion of SARS-CoV-2infections, perhaps in part due to difficulties in determining the timing...
Among patients with non-severe COVID-19 and no risk factors for severe disease receivinga single 400 mcg/kg dose of ivermectin within 72 h of fever or cough onset...
A new variant of SARS-CoV-2, known as VOC-202012/01, is spreading in the UK and israpidly becoming a global threat.1,2 VOC-202012/01 is characterised by multiple...
Although adults with asthma appear to have a reduced risk of severe COVID-19 comparedwith younger populations,1 women with asthma might represent a somewhat susceptible...
Since the onset of the COVID-19 pandemic, SARS-CoV-2 vaccine development has progressedat an unprecedented rate, with recent phase 3 trial data offering the tantalising...
Acute brain dysfunction was highly prevalent and prolonged in critically ill patientswith COVID-19. Benzodiazepine use and lack of family visitation were identified...
By early January, 2021, COVID-19, caused by the severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2), had resulted in more than 83 million confirmed cases...
At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigueor muscle weakness, sleep difficulties, and anxiety or depression. Patients...
Consistent with international society recommendations, renin–angiotensin system inhibitorscan be safely continued in patients admitted to hospital with COVID-19....